International Conference on Oncology, Molecular Biology and Cancer Therapeutics (ICOMBCT - 26)

This track will explore the latest developments in precision medicine as it relates to oncology. Emphasis will be placed on personalized treatment strategies that enhance patient outcomes through tailored therapeutic approaches.

Focusing on the intricate molecular pathways involved in cancer biology, this track aims to elucidate the genetic and epigenetic factors that contribute to tumorigenesis. Presentations will highlight recent discoveries that inform our understanding of cancer progression.

This session will showcase groundbreaking therapeutic strategies in the treatment of various cancers. Participants will discuss novel drug formulations, delivery systems, and combination therapies that are reshaping oncology.

This track will delve into the complex interactions between tumors and their microenvironment, particularly focusing on immune evasion mechanisms. Research presented will highlight how these interactions can be targeted for therapeutic benefit.

The identification and validation of biomarkers are crucial for improving cancer diagnosis and prognosis. This session will cover the latest research on biomarkers that can predict treatment response and disease outcomes.

This track will emphasize the translation of laboratory findings into clinical applications in oncology. Discussions will center around successful case studies and the challenges faced in implementing research into practice.

Focusing on the evolving field of immunotherapy, this session will address current trends, challenges, and future directions in harnessing the immune system to combat cancer. Presentations will include novel agents and combination strategies.

This track will explore the development and application of targeted therapies in the treatment of cancer. Emphasis will be placed on the mechanisms of action, resistance, and clinical outcomes associated with these therapies.

This session will focus on the epidemiological aspects of cancer, including risk factors, prevention strategies, and public health initiatives. Research presented will aim to inform policy and practice in cancer prevention.

This track will highlight innovative technologies that are transforming cancer research, including genomics, proteomics, and bioinformatics. Participants will discuss how these technologies can enhance our understanding of cancer biology.

This session will address the ethical implications of cancer research and treatment, including patient consent, access to therapies, and the role of equity in healthcare. Discussions will aim to foster a responsible approach to oncology practices.